Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 7

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 7
---
 at the Special Meeting, you should contact your broker or agent to obtain a legal proxy and have this proxy available at the Special Meeting in order to vote. Will I be able to ask questions and have these questions answered during the Virtual Special Meeting? Stockholders may submit questions for the Special Meeting after logging in. If you wish to submit a question, you may do so by logging into the virtual meeting platform at www.meetnow.global / M7SKRH9, typing your question into the “Ask a Question” field, and clicking ‘‘Submit.” Please submit any questions before the start time of the meeting. Appropriate questions related to the business of the Special Meeting (the proposals being voted on) will be answered during the Special Meeting, subject to time constraints. How Does the Board of Directors Recommend that I Vote on the Proposals? Our board of directors recommends that you vote as follows: •“ FOR” the approval of, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 347,222,700shares of our common stock underlying the Series A Warrants (assuming full adjustment of the exercise price to the Floor Price of $0.216 per share and exercise pursuant to the zero exercise price provisions of the Series A Warrants) shares of our common stock underlying the Series A Warrants, issued in connection with a private placement and sale of our securities that was consummated on March10, 2025 and certain provisions of the Series A Warrants (the “Issuance Proposal”) •“ FOR” the approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the total number of shares of common stock authorized for issuance thereunder from 100,000,000shares to 800,000,000shares (the “Charter Amendment Proposal”); •“ FOR” the approval of an amendment to our 2023 Equity Incentive Plan (the “2023 Plan”) to (x) increase the number of shares authorized for the issuance of awards by 2,700,000 and (y) to incorporate an evergreen provision to increase the number of shares under the 2023 Plan in future years (the “Equity Incentive Plan Proposal”); 4 •“ FOR” the approval of an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock by a ratio of not less than 1 -for-2and not more than 1